The Food and Drug Administration recently
approved the Adacel (Tdap) vaccine to be administered as soon as 8 years
after a previous dose. Adacel, manufactured by Sanofi Pasteur, provides
immunity to tetanus, diphtheria, and pertussis. The vaccine is approved for
patients ages 10-64, and is available in a syringe made without natural rubber
The current CDC
recommendations for Tdap are as follows:
- Adolescents should receive a single dose,
preferably at age 11 or 12
- All pregnant
women should receive a single dose during pregnancy, preferably between
weeks 27 and 36. By receiving this vaccine, pregnant mothers pass antibodies to
their babies, reducing the risk of whooping cough.
- Adults should receive a single dose of Tdap
followed by a booster Td every 10 years.
FDA approval was based on clinical data from a study that
showed no significant differences in adverse events when adults received Adacel
versus Td 8-12 years after a previous dose of Adacel. The approval of Adacel administration every 8
years provides more flexibility for physicians in both vaccine purchasing
decisions and immunizations scheduling. Sanofi has provided study results to
the CDC for consideration in future recommendations.
For more information or to purchase Adacel or any other
immunization, visit our website
or send us an email.
At CPP’s recent Vaccine Management Summit, 2D barcoding
stood out as a topic of interest among attendees. CPP members will find a new
AAP guide helpful as they continue to learn about this technology.
The AAP recently released a guide
for pediatricians with information on two key information technology topics:
immunization information systems and two dimensional barcoding. In addition,
the AAP provides a detailed website for both topics that summarizes the
information found in the new guide and provides relevant links.
Information Systems, also known as vaccine or immunization registries, are
confidential computerized systems that capture vaccination data across the
lifespan within a certain geographical area. The use of these systems can
reduce healthcare costs and improve patient care. The benefits to pediatric
practices of using these systems include minimizing duplicate vaccine
administration, aiding in recalling patients overdue for vaccinations,
reminding patients of upcoming immunizations, and identifying vulnerable
patients during a disease outbreak.
Dimensional Barcode Scanning Technology can be used with the majority of
pediatric vaccines. Recent studies show that the use of 2D scanning increase
accuracy in vaccine documentation and reduces documentation time by an average
of 21 seconds. 2D barcode scanning improves practice efficiency, increases
vaccine inventory accuracy, and assists in proper billing. In addition, the
technology benefits patients by improving safety and documentation, reducing
errors, and identifying expired vaccines before they are administered to
patients. The AAP’s 2D
barcoding resources include practice uses, choosing a scanner, and getting
the scanner to “work.”
For practices not yet ready to implement 2D barcoding, CPP
has other resources to help manage your vaccine inventory including a Vaccine
Inventory Reconciliation Sheet. These resources can be found on our website.